TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

Rosen Law Firm announces a class action lawsuit against Skye Bioscience for allegedly making false and misleading statements about their drug nimacimab's effectiveness and prospects during the period of November 4, 2024 to October 3, 2025.

Insights
SKYE   negative

Lawsuit alleges company made materially false statements about drug effectiveness, clinical prospects, and regulatory potential, suggesting intentional misrepresentation of business performance